Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

Sundial Stock Is Being Hurt by Late Financial Results Reporting

Sundial stock is being hurt by the cannabis company's late financial results reporting. SNDL stock could move one way or another as Sundial Growers reports its financial results and outlook this week.

Tilray Stock Is a Buy as It Blazes Higher on Today’s Earnings

Tilray stock is soaring after reporting an unexpected profit for its latest quarter and inking a deal with supermarket chain Whole Foods.

Is TLRY Stock a Buy After Earnings? 3 Analysts Weigh In.

Investors are wondering if Tilray (TLRY) stock is a buy after the release of the marijuana company's earnings report for fiscal Q3 2022.

Why Tilray Stock Is Soaring Today

Shares of TLRY stock are climbing after the company reported positive non-GAAP earnings and a new partnership with Whole Foods.

There’s Still a Good Chance Sundial Stock Will Reverse Split

Unless you're looking to make a moonshot wager on pot reform, skip out on SNDL stock.

Dear Tilray (TLRY) Stock Fans, Mark Your Calendars for April 6

For investors in TLRY stock, there are many catalysts to watch. Upcoming earnings on April 6 represent one of these key dates.

Buy Canopy Growth as Congress Works to Decriminalize Marijuana

If Congress can make progress toward marijuana legalization, Canopy Growth will be in prime position to benefit. Let's look at CGC stock now.

Cannabis Stocks Alert: Why Are ACB, CGC, TLRY, SNDL, GRWG, OGI Stocks in Focus Today?

Cannabis stocks are in focus after the House of Representatives just passed the MORE Act. Here is what you need to know.

Why Is Sundial Growers (SNDL) Stock in the Spotlight Today?

Canadian cannabis producer Sundial Growers stock is in focus after announcing that it has completed the purchase of a liquor retailer.

Sundial Growers: All Eyes Are on a Bill to Decriminalize Marijuana

SNDL stock has rallied 22.8% in five days. Investors should watch for any steep selloff amid major upcoming news.

Why Is Tilray (TLRY) Stock Up Today?

TLRY stock and many of its peers are rising after the House officially scheduled a vote for next week on a bill that would legalize cannabis.

Cannabis Stocks: Why Are TLRY, SNDL, CGC, ACB, HEXO, CLVR, OGI, HITI Stocks Up Today?

Cannabis stocks are trending higher across the board on reports that Congress again plans to take up legalization at the federal level.

Why Is Sundial Growers (SNDL) Stock Up Today?

Sundial Growers (SNDL) stock is jumping higher today on renewed optimism that recreational cannabis will soon be legal in the U.S.

Why Is Cresco Labs (CRLBF) Stock in the Spotlight Today?

Cresco Labs has agreed to acquire one of its major rivals, Columbia Care, in exchange for CRLBF stock in a roughly $2 billion deal.

Why Is Aurora Cannabis (ACB) Stock Up Today?

ACB stock is climbing after Aurora announced that it would acquire an award-winning Canadian cannabis company called Thrive.

Why Is Sundial Growers (SNDL) Stock in the Spotlight Today?

SNDL stock is in the spotlight as anticipation over its acquisition of Alcanna heats up. Here's the latest news you should know.

SNDL Stock Has Two Ways to Dramatically Increase in Price

SNDL stock may have tons of trouble but it also has chances to rise in price very soon. Risk-tolerant speculators should keep an eye on it.

Tilray Stock Isn’t a Buy Until It Proves Its Profitability Is Sustainable

TLRY stock has tumbled 80% over the past year, but now expectations for Tilray are even higher after a milestone of net income in Q2 FY22.

Why Sundial Growers Will Continue to Get Smoked at the Market

SNDL stock faces a de-listing possibility while a turnaround in its underlying business seems highly unlikely.